JMIR Publications

ABSTRACT

Background:

An understanding of the technology acceptance of home-based cardiac telerehabilitation (HBCTR) programmes is paramount if they are to be designed and delivered to target the needs and preferences of coronary heart disease (CHD) patients. However, the current state of technology acceptance of HBCTR has not been systematically evaluated in the literature.

Objective:

This scoping review aimed to provide a comprehensive summary of HBCTR technology acceptance in terms of (a) the timing and approaches used and (b) patients’ perspectives on its usability, utility, acceptability, acceptance, and external variables.

Methods:

We searched PubMed, CENTRAL, Embase, CINAHL, PsycINFO and Scopus from inception till July 2021 for English language publications that reported empirical evidence on the technology acceptance of phase 2 HBCTR in patients with CHD. Content analysis was undertaken.

Results:

The search identified 1798 studies, of which 18 studies met eligibility criteria and reported 14 unique HBCTR programmes. Majority of included programmes evaluated technology acceptance at the intra- and post-trial stages using questionnaires (n = 10) and captured usage data (n = 11). Qualitative interviews were the least used approach (n = 3). Usability, utility, acceptability, and acceptance were generally favoured. External variables influencing HBCTR usage included component quality, system quality, facilitating conditions and intrinsic factors.

Conclusions:

HBCTR usability, utility, acceptability, and acceptance were high. Yet, a number of external variables influenced technology acceptance of HBCTR programmes. Findings from this review can be used to provide guidance for stakeholders and clinicians in developing and evaluating patient-centered HBCTR programmes. Clinical Trial: NA